Followers | 579 |
Posts | 24391 |
Boards Moderated | 0 |
Alias Born | 08/15/2007 |
Thursday, January 17, 2019 3:12:53 PM
To date, five Canadian marijuana stocks have chosen to move their listing to one of the two major U.S. exchanges.
Cronos Group (NASDAQ:CRON): Cronos Group became the first pot stock to uplist to a major exchange, in this case the Nasdaq, at the end of February. Expected to be a top-10 producer when at peak capacity, Cronos in July announced a joint venture with a group of investors that'll allow the construction of an 850,000-square-foot greenhouse capable of 70,000 kilograms of annual yield.
Canopy Growth Corp. (NYSE:CGC): Canopy Growth was planning to be the first pot stock to uplist in October 2017. Those plans changed when it received the first of what would become three investments from alcoholic beverage giant Constellation Brands. With Tweed, arguably the best known cannabis brand; superior sales channels; and production capacity that'll probably rank second overall, at around 500,000 kilograms per year at peak capacity, Canopy Growth has certainly benefited from its increased exposure.
Tilray (NASDAQ:TLRY): Though Cronos beat Tilray to the punch of listing on the Nasdaq, Tilray still made history by becoming the first Canadian marijuana stock to go the initial public offering route in the United States. Currently laying the foundation for its international expansion and capacity growth, Tilray is likely to become a top-five producer within the next three years.
Aurora Cannabis (NYSE:ACB): In October, Aurora Cannabis uplisted to the NYSE with the clear intent of attracting long-term investors. Aurora Cannabis is widely expected to be the leading producer by volume in Canada. Inclusive of its ICC Labs acquisition, and the 1.1 million square feet of capacity ICC is developing, Aurora Cannabis should easily surpass 600,000 kilograms in annual production. In other words, it very much deserves its NYSE listing.
Aphria (NYSE:APHA): Last, but not least, Aphria uplisted to the NYSE just days ago. Aphria projects to slide in as the No. 3 grower by annual yield, with an estimated 255,000 kilograms. Aphria's focus on alternative cannabis products, including its under-construction extraction center for concentrates, should play a big role in lifting its operating margin and making the company profitable.
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM